The First made-in-India 'digital pill' for diabetes going to undergo South Asia's first of its kind trial - Digital Intent

PHARMA HEALTHCARE BIOTECH DIGITAL NEWS & VIEWS

Thursday, 16 November 2017

The First made-in-India 'digital pill' for diabetes going to undergo South Asia's first of its kind trial


The #WeDiDiT (Wellthy Digital Diabetes Therapy) trial is all set to prove the efficacy of its 16-week structured diabetes management programme delivered through a mobile app. The outcome of this multi-center randomized control trial will be measured by the HbA1C levels of patients before and after the trial.

Dr. Rajeev Chawla, Current President Elect of RSSDI said, “The need for digital interventions in diabetes care is more now than ever, especially in India. The Wellthy Diabetes intervention is an innovation born out of India, for Indians and South Asians. This clinical trial holds tremendous potential in terms of changing outcomes for persons living with diabetes by making it easier for them to manage their blood sugar levels and improving their overall quality of life.

No comments:

Post a Comment